Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Octave
Octave Bioscience is a precision medicine company focused on advancing care for neurodegenerative diseases, starting with multiple sclerosis (MS). Their flagship product, the Octave MSDA Test, is the…
Octave
Octave Bioscience is a precision medicine company focused on advancing care for neurodegenerative diseases, starting with multiple sclerosis (MS). Their flagship product, the Octave MSDA Test, is the…
TL;DR
Focus: Blood-based multi-protein biomarker assays for multiple sclerosis (MS) and neurodegenerative diseases
Flagship product: Octave MSDA Test — multi-analyte blood test to measure MS disease activity
Business model: SaaS plus diagnostic (laboratory test) delivery
Headcount: 84 employees
Funding (reported): $122,840,000 total disclosed funding
Company Overview
Problem Domain
Measurement of disease activity in multiple sclerosis and related neurodegenerative diseases to support clinical decision-making.
Industry
Biotech / Molecular diagnostics / Precision medicine
Funding Track Record
Public profiles report a Series B on Jul 26, 2023
Public profiles indicate a Series C announced in 2025
Strategic investment announced Oct 11, 2021
Investor Signal
“Syndicate includes strategic and life-science investors such as Merck Global Health Innovation Fund, Northpond Ventures, S32, Casdin Capital, and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week